Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fosinopril sodium |
Is a |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fosinopril (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosinopril adverse reaction |
Causative agent (attribute) |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosinopril allergy |
Causative agent (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fosinopril- and hydrochlorothiazide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fosinopril pseudoallergy |
Causative agent (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fosinopril pseudoallergy |
Causative agent (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fosinopril pseudoallergy |
Causative agent (attribute) |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosinopril sodium |
Is modification of (attribute) |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosinopril-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fosinopril and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fosinopril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fosinopril and hydrochlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fosinopril and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fosinopril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosinopril (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |